Clinical Trial Update: A Multicenter Study of rhFGF 18 in Patients With Knee Osteoarthritis Not Requiring Surgery [Phase 1]

View source ↗

Summary

A multicenter Phase 1 trial evaluating rhFGF18 for knee osteoarthritis not requiring surgery has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Knee Osteoarthritis

Drugs mentioned

• rhFGF18 (recombinant human fibroblast growth factor 18)

Snippet

Sponsor: Merck KGaA, Darmstadt, Germany | Conditions: Knee Osteoarthritis | Phase 1 | Status: COMPLETED